Fair call healthy, there is alot Is priced in.
I still believe in the growth profile and believe it will still keep going at the 20-30% rate. Also the focus on reinvesting cash as fully as possible I believe will continue to pay off.
If XRO pulled back on some of that spend they would be far more profitable than they look.
Intuit is the clear big competitor which is certainly an issue to watch. But outside that the barriers to entry to get into this area of business are tough to enter.
November report needs to be good or this will get a share price hammering, I am confident it will be positive.
Time will tell which it goes
- Forums
- ASX - By Stock
- XRO
- Xero to $200
Xero to $200, page-308
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$161.14 |
Change
1.520(0.95%) |
Mkt cap ! $24.61B |
Open | High | Low | Value | Volume |
$160.55 | $161.66 | $158.99 | $74.60M | 464.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1184 | $160.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$161.14 | 879 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1184 | 160.710 |
1 | 141 | 160.610 |
1 | 1184 | 160.580 |
1 | 1184 | 160.450 |
1 | 2483 | 160.400 |
Price($) | Vol. | No. |
---|---|---|
161.140 | 879 | 1 |
161.310 | 1184 | 1 |
161.390 | 141 | 1 |
161.400 | 23 | 1 |
161.440 | 1184 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
XRO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online